A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
This study has been completed.
Study NCT01499368
Information provided by Boryung Pharmaceutical Co., Ltd
First Received on December 21, 2011.
Last Updated on January 23, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
